top of page
Search

Hospital-Acquired Infections (C. diff/H. pylori) for MRCP Part 1

TL;DR

Hospital-Acquired Infections (C. diff/H. pylori) are commonly tested topics in MRCP Part 1, especially in questions involving antibiotic exposure, gastrointestinal disease, and infection control. Clostridioides difficile causes antibiotic-associated colitis in hospitalised patients, while Helicobacter pylori is strongly linked to peptic ulcer disease and gastric malignancy. Candidates should know the risk factors, diagnostic tests, and treatment regimens for both organisms. This guide summarises the most tested concepts, exam traps, and practical revision strategies.


Why this matters

In MRCP Part 1, infectious disease questions frequently integrate microbiology, pharmacology, and clinical reasoning. Hospital-acquired infections are particularly high yield because they involve both patient safety and antimicrobial stewardship.

Two organisms frequently appear in exam questions:

  • Clostridioides difficile (C. diff) – the most common cause of antibiotic-associated diarrhoea in hospital settings

  • Helicobacter pylori (H. pylori) – a key pathogen in peptic ulcer disease and gastric cancer

A solid understanding of their pathophysiology, diagnostic approach, and management is essential for exam success. If you are preparing systematically, start with the MRCP Part 1 overview and reinforce learning using Free MRCP MCQs.


Core Sections

1. Clostridioides difficile: Pathogenesis

C. difficile is a Gram-positive, spore-forming anaerobic bacterium that colonises the colon.

It produces toxins A and B, which cause:

  • Mucosal inflammation

  • Epithelial cell damage

  • Pseudomembrane formation

These mechanisms explain the classic clinical presentation of pseudomembranous colitis.

Key epidemiological points:

  • Spread via faeco-oral transmission

  • Spores survive in hospital environments

  • Alcohol gel is ineffective against spores

This explains why strict infection control measures are necessary.

2. Risk Factors for C. difficile Infection

MRCP questions frequently provide subtle clues pointing toward C. difficile infection.

Common risk factors include:

  1. Recent broad-spectrum antibiotic use

  2. Hospitalisation or long-term care admission

  3. Advanced age (>65 years)

  4. Proton pump inhibitor therapy

  5. Severe comorbid illness

  6. Immunosuppression

  7. Previous C. difficile infection

  8. Prolonged hospital stay

High-risk antibiotics include:

  • Clindamycin

  • Fluoroquinolones

  • Cephalosporins

  • Broad-spectrum penicillins

Recognising these clues in the exam stem is often the key to identifying the diagnosis.

3. Diagnosis of C. difficile Infection

Diagnosis relies primarily on stool testing for toxins.

The typical diagnostic pathway includes:

  • Clinical suspicion in patients with ≥3 loose stools within 24 hours

  • Laboratory detection of toxin genes using PCR

  • Detection of toxins A or B in stool

Important exam principle:

Testing should only be performed on unformed stool samples.

Testing formed stool may produce false results and is discouraged.

Guidelines from the UK Health Security Agency and NICE emphasise appropriate testing to avoid overdiagnosis.

4. Treatment of C. difficile Infection

Treatment depends on the severity of infection.

Severity

First-Line Treatment

Key Points

Non-severe

Oral vancomycin

Preferred therapy

Severe

Oral vancomycin or fidaxomicin

Monitor closely

Fulminant

High-dose oral vancomycin + IV metronidazole

Surgical review may be needed

Key management steps include:

  • Stop the offending antibiotic

  • Maintain hydration

  • Implement infection control measures

Recurrent infection is common and may require faecal microbiota transplantation (FMT).

The National Institute for Health and Care Excellence (NICE) provides updated guidance on therapy:https://www.nice.org.uk/guidance/ng199

5. Helicobacter pylori: Pathogenesis

Helicobacter pylori is a Gram-negative spiral bacterium adapted to survive in the acidic stomach environment.

It produces several important virulence factors:

  • Urease enzyme – neutralises gastric acid

  • Cytotoxin-associated gene A (CagA)

  • Vacuolating cytotoxin (VacA)

Chronic infection leads to:

  • Gastric mucosal inflammation

  • Increased gastric acid secretion (duodenal ulcers)

  • Gastric atrophy and intestinal metaplasia

Long-standing infection increases the risk of gastric adenocarcinoma and MALT lymphoma.

6. Diagnostic Tests for H. pylori

Several diagnostic methods are commonly tested in MRCP Part 1.

Test

Principle

Clinical Use

Urea breath test

Detects urease activity

Preferred non-invasive test

Stool antigen test

Detects bacterial antigen

Diagnosis and follow-up

Endoscopic biopsy

Histology or rapid urease test

Alarm symptoms present

Serology

Antibody detection

Less commonly used

Important exam point:

Proton pump inhibitors must be stopped before testing, as they can reduce bacterial load and cause false-negative results.

NICE guidance on dyspepsia and H. pylori management is available here:https://www.nice.org.uk/guidance/cg184

7. H. pylori Treatment Regimens

Eradication therapy involves combination antibiotic treatment with acid suppression.

Standard triple therapy includes:

  • Proton pump inhibitor

  • Clarithromycin

  • Amoxicillin or metronidazole

Treatment duration:

7–14 days depending on clinical guidelines

After therapy, eradication should be confirmed using a urea breath test or stool antigen test.

8. Key Differences Between C. difficile and H. pylori

Feature

C. difficile

H. pylori

Transmission

Hospital environment

Oral-oral or faeco-oral

Primary disease

Antibiotic-associated colitis

Peptic ulcer disease

Diagnostic test

Stool toxin/PCR

Urea breath test

Treatment

Vancomycin / fidaxomicin

Triple therapy

Understanding these differences helps candidates rapidly interpret exam stems.


Practical Example / Mini Case

A 70-year-old man is admitted with pneumonia and treated with intravenous ceftriaxone. Five days later he develops profuse watery diarrhoea, abdominal pain, and fever.

Which is the most appropriate investigation?

A. Stool cultureB. ColonoscopyC. Stool toxin assayD. CT abdomen

Correct answer: C — Stool toxin assay

Explanation:

Recent antibiotic therapy combined with acute diarrhoea strongly suggests Clostridioides difficile infection. Diagnosis is confirmed using stool toxin or PCR testing.


Practical Study Tip Checklist

When revising Hospital-Acquired Infections (C. diff/H. pylori) for MRCP Part 1, ensure you can answer the following quickly:

✔ Identify antibiotics most commonly associated with C. diff✔ Recognise pseudomembranous colitis symptoms✔ Know that oral vancomycin is first-line treatment✔ Understand the role of urease in H. pylori survival✔ Recall the components of triple therapy✔ Remember to stop PPIs before urea breath testing✔ Associate H. pylori with MALT lymphoma and gastric cancer

Practising exam-style questions is one of the most effective ways to consolidate this knowledge. You can attempt timed practice using Start a mock test or review key concepts through MRCP revision lectures.


Medical student studying infectious diseases and microbiology notes for MRCP Part 1 exam preparation.

Common Pitfalls (Exam Traps)

  1. Testing formed stool for C. difficile.

  2. Forgetting that alcohol hand gel does not kill C. diff spores.

  3. Using metronidazole alone for severe C. diff infection.

  4. Not stopping proton pump inhibitors before H. pylori testing.

  5. Missing the association between H. pylori and gastric MALT lymphoma.

Recognising these traps significantly improves accuracy in infectious disease questions.


FAQs

Is Clostridioides difficile always hospital-acquired?

No. Community-acquired infections occur, but most MRCP Part 1 questions involve recent antibiotic exposure or hospital admission.

Why is soap and water recommended instead of alcohol gel for C. diff?

C. difficile forms spores that are resistant to alcohol-based sanitiser. Mechanical washing with soap and water removes spores effectively.

Which diseases are associated with Helicobacter pylori?

Major associations include duodenal ulcers, gastric ulcers, gastric adenocarcinoma, and gastric MALT lymphoma.

How is eradication of H. pylori confirmed?

Eradication is usually confirmed using a urea breath test or stool antigen test after treatment.

Why are hospital infections commonly tested in MRCP Part 1?

They combine microbiology, pharmacology, infection control, and clinical medicine, making them ideal topics for integrated exam questions.


Ready to start?

Success in MRCP Part 1 depends on recognising high-yield clinical patterns and practising exam questions regularly. Strengthen your preparation with the Free MRCP MCQs and explore the full MRCP Part 1 overview to structure your revision effectively.

Start your preparation here:👉 https://www.crackmedicine.co.uk

You can also explore:


Sources

 
 
 

Comments

bottom of page